세계의 바이오일렉트로닉스 의료 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 제품별, 용도별, 최종 사용자별, 지역별 경쟁(2020-2030년)
Bioelectronic Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type, By Product, By Application, By End User, By Region and Competition, 2020-2030F
세계의 바이오일렉트로닉스 의료 시장 규모는 2024년에 235억 4,000만 달러로 평가되었고, 2030년에는 335억 9,000만 달러에 이르고, 예측 기간 중 CAGR은 6.10%를 나타낼 것으로 전망됩니다.
시장 성장의 원동력이 되고 있는 것은 심혈관 질환이나 신경 질환 등의 만성 질환에 대한 고도의 헬스 케어 솔루션에 대한 수요 증가입니다. 제세동기 등의 기기의 사용도 보급되어 있습니다. 부작용의 경감이나 환자의 결과의 개선 등, 이러한 기기에 관련하는 이점에 대한 인식이 높아지고 있는 것도, 수요를 한층 더 가속하고 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030 |
| 시장 규모 : 2024년 |
235억 4,000만 달러 |
| 시장 규모 : 2030년 |
335억 9,000만 달러 |
| CAGR : 2025-2030년 |
6.10% |
| 급성장 부문 |
미주 신경 자극기 |
| 최대 시장 |
북미 |
시장 성장 촉진요인
만성 질환 증가와 노화
주요 시장 과제
높은 비용과 제한된 상환 정책
주요 시장 동향
디지털 건강 및 인공지능과의 통합
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 임상시험 분석
제6장 세계의 바이오일렉트로닉스 의료 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 유형별(이식형, 비침습형)
- 제품별(이식형 제세동기, 심장박동기, 인공와우, 척수 자극기, 심부 뇌 자극기, 경피적 전기 신경 자극기, 천골 신경 자극기, 미주 신경 자극기, 기타)
- 용도별(부정맥, 통증 관리, 감각신경성 난청, 파킨슨병, 떨림, 우울증, 치료 저항성 우울증, 간질, 요실금 및 변실금, 기타)
- 최종 사용자별(병원, 개인 사용자, 재택 케어 센터, 외래수술센터(ASC), 전문 클리닉, 기타)
- 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
- 기업별(2024년)
- 시장 맵
제7장 북미의 바이오일렉트로닉스 의료 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 북미 : 국가별 분석
제8장 유럽의 바이오일렉트로닉스 의료 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 유럽 : 국가별 분석
제9장 아시아태평양의 바이오일렉트로닉스 의료 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 아시아태평양 : 국가별 분석
제10장 남미의 바이오일렉트로닉스 의료 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 남미 : 국가별 분석
제11장 중동 및 아프리카의 바이오일렉트로닉스 의료 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 중동 및 아프리카 : 국가별 분석
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
제12장 시장 역학
제13장 시장 동향과 발전
제14장 세계의 바이오일렉트로닉스 의료 시장 : SWOT 분석
제15장 Porter's Five Forces 분석
- 업계 내 경쟁
- 신규 진입의 가능성
- 공급자의 협상력
- 고객의 협상력
- 대체품의 위협
제16장 경쟁 구도
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Cochlear Ltd.
- LivaNova PLC
- Soterix Medical Inc.
- Bioinduction Ltd.
- GiMer Medical
- CEFALY
- BioControl Medical
제17장 전략적 제안
제18장 기업 소개와 면책사항
KTH
The Global Bioelectronic Medicine Market was valued at USD 23.54 billion in 2024 and is projected to reach USD 33.59 billion by 2030, growing at a CAGR of 6.10% during the forecast period. Market growth is being driven by rising demand for advanced healthcare solutions for chronic illnesses such as cardiovascular and neurological disorders. Increasing governmental support and investments in the development of bioelectronic therapies are boosting global adoption. Additionally, with greater integration of technology in healthcare, the use of devices like pacemakers and defibrillators is becoming more widespread. The growing awareness of the benefits associated with these devices-such as reduced side effects and improved patient outcomes-further accelerates demand. These factors, coupled with rising disposable incomes and a growing aging population, are expected to sustain the upward trajectory of the bioelectronic medicine market globally.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 23.54 Billion |
| Market Size 2030 | USD 33.59 Billion |
| CAGR 2025-2030 | 6.10% |
| Fastest Growing Segment | Vagus Nerve Stimulators |
| Largest Market | North America |
Key Market Drivers
Rising Prevalence of Chronic Diseases and Aging Population
The increasing global burden of chronic diseases-such as cardiovascular ailments, diabetes, and neurological disorders-is significantly contributing to the expansion of the bioelectronic medicine market. These long-term conditions often require continuous and targeted treatment approaches. Bioelectronic medicine, which includes technologies like pacemakers and neurostimulators, offers precise and less invasive alternatives to conventional pharmaceuticals. According to WHO, cardiovascular diseases account for nearly 17.9 million deaths annually, making them the leading cause of mortality worldwide. Similarly, the International Diabetes Federation estimated that 537 million adults lived with diabetes in 2021-a figure projected to grow to 643 million by 2030. This trend is further compounded by global demographic shifts, with one in six individuals expected to be over 65 by 2050. These factors collectively emphasize the need for reliable and innovative bioelectronic interventions, especially among elderly populations who are more vulnerable to chronic illnesses and adverse drug reactions.
Key Market Challenges
High Costs and Limited Reimbursement Policies
Despite its therapeutic potential, the bioelectronic medicine market faces challenges related to the high cost of devices and limited reimbursement coverage. Advanced implantable devices such as neurostimulators and defibrillators involve complex manufacturing processes and high R&D investments, resulting in substantial costs. In low- and middle-income countries, these high prices often place such treatments out of reach for a significant portion of the population. Furthermore, reimbursement frameworks for bioelectronic therapies are inconsistent across regions. In many cases, insurance does not fully cover the cost of treatment, making it financially burdensome for patients. WHO data shows that out-of-pocket medical expenses push approximately 100 million people into extreme poverty every year. These economic constraints hinder wider adoption and market penetration of bioelectronic medical solutions, especially in developing healthcare systems.
Key Market Trends
Integration with Digital Health and Artificial Intelligence
A major trend shaping the bioelectronic medicine market is the integration of digital health technologies and artificial intelligence (AI). AI is enhancing the precision and effectiveness of bioelectronic therapies by enabling real-time analysis of patient data and supporting personalized treatment protocols. Wearable bioelectronic devices are increasingly being used for continuous health monitoring, allowing for early intervention and proactive care. Government bodies are actively promoting these digital advancements. For example, the U.S. Department of Health and Human Services supports the adoption of AI in healthcare to improve efficiency and patient outcomes. Similarly, the European Commission's strategy for digital health encourages the implementation of smart medical technologies. The convergence of AI, data analytics, and bioelectronic medicine is paving the way for next-generation diagnostics and therapeutics, while also facilitating remote care and expanding access to treatment.
Key Market Players
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Cochlear Ltd.
- LivaNova PLC
- Soterix Medical Inc.
- Bioinduction Ltd.
- GiMer Medical
- CEFALY
- BioControl Medical
Report Scope:
In this report, the Global Bioelectronic Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Bioelectronic Medicine Market, By Type:
Bioelectronic Medicine Market, By Product:
- Implantable cardioverter defibrillators
- Cardiac pacemakers
- Cochlear implants
- Spinal cord stimulators
- Deep brain stimulators
- Transcutaneous electrical nerve stimulators
- Sacral nerve stimulators
- Vagus nerve stimulators
- Others
Bioelectronic Medicine Market, By Application:
- Arrhythmia
- Pain management
- Sensorineural hearing loss
- Parkinson's disease
- Tremor
- Depression
- Treatment-resistant depression
- Epilepsy
- Urinary and fecal incontinence
- Others
Bioelectronic Medicine Market, By End User:
- Hospitals
- Individual Users
- Homecare Centers
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Bioelectronic Medicine Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bioelectronic Medicine Market.
Available Customizations:
Global Bioelectronic Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
- 5.1. Ongoing Clinical Trials
- 5.2. Completed Clinical Trials
- 5.3. Terminated Clinical Trials
- 5.4. Breakdown of Pipeline, By Development Phase
- 5.5. Breakdown of Pipeline, By Status
- 5.6. Breakdown of Pipeline, By Study Type
- 5.7. Breakdown of Pipeline, By Region
- 5.8. Clinical Trials Heat Map
6. Global Bioelectronic Medicine Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Implantable, Non-invasive)
- 6.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
- 6.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
- 6.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
- 6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
- 6.2.6. By Company (2024)
- 6.3. Market Map
- 6.3.1. By Product
- 6.3.2. By Application
- 6.3.3. By Technique
- 6.3.4. By Source
- 6.3.5. By Region
7. North America Bioelectronic Medicine Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Type (Implantable, Non-invasive)
- 7.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
- 7.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
- 7.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
- 7.2.5. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Bioelectronic Medicine Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Product
- 7.3.1.2.3. By Application
- 7.3.1.2.4. By End User
- 7.3.2. Canada Bioelectronic Medicine Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Product
- 7.3.2.2.3. By Application
- 7.3.2.2.4. By End User
- 7.3.3. Mexico Bioelectronic Medicine Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Product
- 7.3.3.2.3. By Application
- 7.3.3.2.4. By End User
8. Europe Bioelectronic Medicine Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Type (Implantable v/s Non-invasive)
- 8.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
- 8.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
- 8.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
- 8.2.5. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Bioelectronic Medicine Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Product
- 8.3.1.2.3. By Application
- 8.3.1.2.4. By End User
- 8.3.2. Germany Bioelectronic Medicine Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Product
- 8.3.2.2.3. By Application
- 8.3.2.2.4. By End User
- 8.3.3. United Kingdom Bioelectronic Medicine Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Product
- 8.3.3.2.3. By Application
- 8.3.3.2.4. By End User
- 8.3.4. Italy Bioelectronic Medicine Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Product
- 8.3.4.2.3. By Application
- 8.3.4.2.4. By End User
- 8.3.5. Spain Bioelectronic Medicine Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Product
- 8.3.5.2.3. By Application
- 8.3.5.2.4. By End User
9. Asia-Pacific Bioelectronic Medicine Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Type (Implantable v/s Non-invasive)
- 9.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
- 9.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
- 9.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
- 9.2.5. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Bioelectronic Medicine Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Product
- 9.3.1.2.3. By Application
- 9.3.1.2.4. By End User
- 9.3.2. India Bioelectronic Medicine Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Product
- 9.3.2.2.3. By Application
- 9.3.2.2.4. By End User
- 9.3.3. Japan Bioelectronic Medicine Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Product
- 9.3.3.2.3. By Application
- 9.3.3.2.4. By End User
- 9.3.4. South Korea Bioelectronic Medicine Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Type
- 9.3.4.2.2. By Product
- 9.3.4.2.3. By Application
- 9.3.4.2.4. By End User
- 9.3.5. Australia Bioelectronic Medicine Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Type
- 9.3.5.2.2. By Product
- 9.3.5.2.3. By Application
- 9.3.5.2.4. By End User
10. South America Bioelectronic Medicine Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Type (Implantable v/s Non-invasive)
- 10.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
- 10.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
- 10.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
- 10.2.5. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Bioelectronic Medicine Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Product
- 10.3.1.2.3. By Application
- 10.3.1.2.4. By End User
- 10.3.2. Argentina Bioelectronic Medicine Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Product
- 10.3.2.2.3. By Application
- 10.3.2.2.4. By End User
- 10.3.3. Colombia Bioelectronic Medicine Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Product
- 10.3.3.2.3. By Application
- 10.3.3.2.4. By End User
11. Middle East and Africa Bioelectronic Medicine Market Outlook
- 11.1. Market Size & Forecast
- 11.2. Market Share & Forecast
- 11.2.1. By Type (Implantable v/s Non-invasive)
- 11.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
- 11.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
- 11.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
- 11.2.5. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Bioelectronic Medicine Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Type
- 11.3.1.2.2. By Product
- 11.3.1.2.3. By Application
- 11.3.1.2.4. By End User
- 11.3.2. Saudi Arabia Bioelectronic Medicine Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Type
- 11.3.2.2.2. By Product
- 11.3.2.2.3. By Application
- 11.3.2.2.4. By End User
- 11.3.3. UAE Bioelectronic Medicine Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Type
- 11.3.3.2.2. By Product
- 11.3.3.2.3. By Application
- 11.3.3.2.4. By End User
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
- 13.1. Recent Developments
- 13.2. Mergers & Acquisitions
- 13.3. Product Launches
14. Global Bioelectronic Medicine Market: SWOT Analysis
15. Porter's Five Forces Analysis
- 15.1. Competition in the Industry
- 15.2. Potential of New Entrants
- 15.3. Power of Suppliers
- 15.4. Power of Customers
- 15.5. Threat of Substitute Products
16. Competitive Landscape
- 16.1. Medtronic plc
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (As Reported)
- 16.1.5. Recent Developments
- 16.1.6. Key Personnel Details
- 16.1.7. SWOT Analysis
- 16.2. Abbott Laboratories
- 16.3. Boston Scientific Corporation
- 16.4. Cochlear Ltd.
- 16.5. LivaNova PLC
- 16.6. Soterix Medical Inc.
- 16.7. Bioinduction Ltd.
- 16.8. GiMer Medical
- 16.9. CEFALY
- 16.10. BioControl Medical
17. Strategic Recommendations
18. About Us & Disclaimer
